Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronicles in drug discovery.

Maria Angels Moral1, Valeria K Khurdayan, Jordi Bozzo

  • 1Prous Science Medical Information Department, Barcelona, Spain. journals@prous.com

Drug News & Perspectives
|December 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021
Same author

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.

Expert review of anti-infective therapy·2017
Same author

Take-home message: are we "off target"?

Drug news & perspectives·2007
Same author

Spotlight on autoimmune lymphoproliferative syndrome.

Drug news & perspectives·2007
Same author

Stem cells: therapeutic present and future.

Drug news & perspectives·2007

Chemoprevention strategies aim to reduce cancer risk using agents that halt carcinogenic processes. Several agents, including Bowman-Birk inhibitor concentrate, budesonide, NCX-4016, and statins, are in clinical trials for various cancers.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Prevention

Background:

  • Chemoprevention is a promising strategy to reduce cancer incidence and mortality.
  • Identifying safe and effective chemopreventive agents is a critical area of cancer research.
  • Carcinogenic processes can be targeted by specific agents to prevent cancer development.

Purpose of the Study:

  • To review the progress in the development of chemopreventive agents.
  • To highlight agents currently under clinical investigation for cancer prevention.
  • To discuss the potential of these agents in reducing the risk of specific cancers.

Main Methods:

  • Review of current clinical trial data and research findings.
  • Focus on agents with demonstrated potential in preclinical and clinical studies.

Related Experiment Videos

  • Analysis of chemopreventive strategies for various cancer types.

    • Main Results:

    • Bowman-Birk inhibitor concentrate is being investigated for head and neck cancers.
    • Budesonide shows potential as a chemopreventive agent for lung cancer.
    • NCX-4016 and statins are under investigation for colon and breast cancer prevention, respectively.

    Conclusions:

    • Several agents are progressing through clinical trials for cancer chemoprevention.
    • These agents offer potential new strategies to reduce cancer risk.
    • Further research is essential to establish the safety and efficacy of these chemopreventive agents.